Clinical Trials · NCT07752381

A Clinical Trial to Evaluate the Effects of Peptide Gummies on Markers of Inflammation, Physical Performance, and Recovery

CompletedN/ABPC-157 (Approved)
Phase
N/A
Recruitment status
Completed
Sponsor
Parlay Wellness
Enrollment
40
Start date
Sep 2025
Locations
1 site, United States
Primary endpoint
Change in High-Sensitivity C-Reactive Protein (hs-CRP)
View BPC-157 compound reference